Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201211000449232Not yet recruiting
Trial of sulfadoxine + pyrimethamine and piperaquine in malaria (3 arms), sponsored by University of Antwerp. Primary endpoint: Hemoglobin concentration. Planned start Sep 2012; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201211000449232.